TB Alliance CEO, Dr. Mel Spigelman, on Sirius Radio
TB Alliance CEO, Dr. Mel Spigelman, was interviewed on Doctor Radio on Sirius. Those who think U.S. residents aren’t significantly
TB Alliance CEO, Dr. Mel Spigelman, was interviewed on Doctor Radio on Sirius. Those who think U.S. residents aren’t significantly
(Durban, SOUTH AFRICA,) The TB Alliance today announced the launch of a collaboration with the National Institute of Allergy and
· AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization sign partnership to share information on TB drugs
Today, the global health community mourns the loss of Winstone Zulu, an immeasurably brave and tireless advocate for access to
The World Health Organization (WHO) reports for the first time that the number of people falling ill with tuberculosis (TB)
The September 2011 issue of Pharmaceutical Executive featured a cover story on the significant impact global health PDPs are making
Clofazamine is a drug from the riminophenazine class that was developed in the 1950s for use against leprosy, but which
The TB Alliance and its partners will be presenting recent advances in TB research and development at the ICAAC 2011
Buoyed by the support of the CPTR initiative and its partners, clinical TB drug regimen development efforts are already underway.
New TB drugs are critically important for TB elimination. Introduction of future TB treatments is more likely to be a